Business Wire

FourKites Named a Leader in the 2024 Gartner® Magic Quadrant™ for Fourth Consecutive Year

2.4.2024 09:00:00 EEST | Business Wire | Press release

Share

Leading real-time supply chain visibility company FourKites ® today announced that, for the fourth consecutive year, it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Real-Time Transportation Visibility Platforms* (RTTVPs). Gartner evaluated seven vendors for its report, and FourKites has been recognized as a Leader both for its Ability to Execute and Completeness of Vision.

FourKites, the world’s largest global visibility platform, tracks over 3.2 million shipments per day across all modes and connects the global supply chains of over 50% of the Fortune 500, including customers such as Cardinal Health, Bayer, Henkel, Dow, Cargill, Coca-Cola, Constellation Brands, 3M, RHI Magnesita and Eastman. In 2023, FourKites saw 25% YoY growth in global customers — now totaling over 1,500; a 31% increase in its carrier network; and 37% growth in connected facilities, the latter of which now total over 3.2 million individual facilities around the world.

"We're honored to be recognized as a Leader by Gartner once again," said FourKites founder and CEO Mathew Elenjickal. "This past year, we not only maintained our growth trajectory, but also achieved a significant milestone by establishing long-term financial independence with zero burn and positive cash flow. Our unwavering commitment to customer-driven innovation has allowed us to deliver unparalleled ROI, while our accelerated customer support processes ensure that we remain the best long-term partner for our enterprise customers. As we move forward, we will continue to push the boundaries of supply chain visibility and empower our customers to navigate the complexities of today's global supply chains with confidence."

Having pioneered the real-time transportation visibility category in 2014, FourKites was the first company to extend real-time visibility across supply chains end-to-end, from yards to warehouses and more. Its industry-first product innovations include real-time facility manager Dynamic Yard; end-to-end international ocean shipments tracker Dynamic Ocean; patented AI-powered ETA forecaster Smart Forecasted Arrival; and automated universal appointment scheduler Appointment Manager.

Moreover, FourKites is the only visibility platform to offer a full order lifecycle tracking solution, Order Visibility, which provides earlier insights and alerts that start during the order planning process — well before a shipment is picked up. Most recently, FourKites launched generative AI assistant Fin AI, which helps customers surface buried insights; identify opportunities for optimization; and automate time-consuming tasks, such as assessing the impact of events across a shipment network.

Over the past year, in recognition of its market-leading innovation, FourKites was named a Best Workplace for Innovators by Fast Company; it was the only supply chain visibility provider on FreightWaves’ FreightTech 25; and it was recognized as a top-10 company for AI and ML in supply chain by Analytics Insight. In addition, FourKites received the 2023 Gartner Marketing and Communications Award for Thought Leadership and Data-Rich Insights for dissemination of real-time data and deep industry analysis throughout recent supply chain disruptions.

What Customers Are Saying on Gartner Peer Insights™

FourKites continues to earn accolades for its unique customer-driven innovation model; for the maturity of its end-to-end, multimodal platform; and for its unwavering commitment to customer success.

“FourKites has proven to be an innovative partner that began by providing visibility to our shipments and delivery status. They have strategically expanded their offering to provide solutions that provide visibility to customer orders throughout the supply chain life cycle.”
Manager, Data Analytics, Consumer Goods Industry

“FourKites is one of the easiest systems to use! Its usage is unparalleled across the competition.”
Logistics Engineering Manager, Manufacturing Industry

“FourKites helps our team provide more accurate visibility to shipment ETAs to the business to enable improved manufacturing decision-making processes.”
Logistics Lead, Manufacturing Industry

“Why aren’t you using FourKites? Our software is integrated and does everything automated behind the scenes. We utilize this product for many of our Shippers, this allows us to transmit status updates real time as well as keeps the history for review months down the road."
Senior Sales Executive, Transportation Industry

“FourKites delivers what it promises: end-to-end visibility for a great customer experience.”
Logistics Operations Strategy Manager, Transportation Industry

“The overall experience with Fourkites products, implementation team, and overall customer service has been excellent.”
Director of Operations, Transportation Industry

“The FourKites Core Track and Appointment Manager platforms are built on a solid technological footing and are performing very well. The technical roadmap of FourKites is impressive out to 2/3 years and the leadership team is impressive.”
Senior Manager, Transportation Optimization, Consumer Goods Industry

Gartner Disclaimer

​​*Gartner, Magic Quadrant for Real-Time Transportation Visibility Platforms, Carly West, Oscar Sanchez Duran, Nathan Lease, 26 March, 2024.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About FourKites

Leading global supply chain visibility platform FourKites empowers business leaders with comprehensive visibility into transportation, yards, warehouses, stores, and beyond. Tracking more than 3.2 million shipments daily across road, rail, ocean, air, parcel, and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitize their end-to-end supply chains. More than 1,500 of the world’s most recognized brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient, and sustainable supply chains. To learn more, visit https://www.fourkites.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Marianna Vyridi
Big Valley Marketing for FourKites
(650) 468-3263
mvyridi@bigvalley.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye